![]() Procedure of control of adherence to medical treatments (Machine-translation by Google Translate, no
专利摘要:
Procedure of adherence control to medical treatments that by means of a mobile phone and a label that incorporates a qr code or an nfc chip associated with a specific container of a specific medication allows to notify and control the degree of follow-up of the prescribed treatment guidelines. A patient by his doctor. (Machine-translation by Google Translate, not legally binding) 公开号:ES2608898A1 申请号:ES201631626 申请日:2016-12-20 公开日:2017-04-17 发明作者:Emilio MATESANZ SÁEZ;Manuel VILLA PALENCIA 申请人:Cudem Servicios Y Soluciones S L;Cudem Servicios Y Soluciones SL; IPC主号:
专利说明:
5 10 fifteen twenty 25 30 DESCRIPTION Procedure for controlling adherence to medical treatments Object of the invention The object of the present invention is a novel method that increases the adherence to patients' drug treatments. Background of the invention The World Health Organization defines adherence to a treatment as compliance with it; that is, to take the medication according to the dosage and the program prescribed by the doctor, and the persistence, to take the medication throughout the indicated treatment time. The most frequent errors of the patients that generate their lack of adherence to one treatment are the forgetfulness of the schedule of the shots, the mistake of one medication for another when you have to ingest several and the taking of double doses when taking a medication twice when it only had to be taken once. Among the consequences of the lack of adherence to a treatment we can mention: • The patient's quality of life worsens. • Prevents disease control. • It generates a greater probability of recap and aggravation. • May induce side effects or poisoning. • May increase the chances of death. • It represents an increase in socio-health resources. • From the medical point of view, it can make the treatments ineffective due to the appearance of resistance or favor the greater virulence of the disease. The World Health Organization itself has defined different strategies to increase adherence that affect different actors: 5 10 fifteen twenty 25 30 • For the doctor: adjust the treatment to the client's needs and simplify it to the maximum, the correct information and instructions to the patient, confirm in each consultation the adequate follow-up of the treatment, use didactic materials and identify goals and share them with the client. In the same line, strategies are established for other types of health professionals such as pharmacists or nurses. • For institutions: create training tools for doctors and patients, provide tools for detecting the magnitude of the problem and generate changes in patient behavior, encourage the participation of health workers and the implementation of assistance and counseling programs telephone. • For the patient: he must adopt a sense of compliance and responsibility for the intake, he must comply with each of the doctor's written instructions, he must involve his family and friends in adherence, he must participate in his illness and be responsible for the Decisions taken, who suffer from chronic diseases should understand that they are a continuous process and that their efforts will provide a better quality of life. The present invention advocates a novel method, which is at the same time a tool that falls within the strategy of the physicians, the institutions and companies involved and the patients, which reminds the patient of the dose to be taken, how often and during how much time has to take it, allowing doctors and institutions to monitor the degree of compliance with treatments so that they can take appropriate corrective measures. Description of the invention The procedure for controlling adherence to medical treatments, which is the object of the present invention, is those that carry it out through computer systems, said computer systems are those that comprise a web server that includes web server software charged, one or more smart mobile phones that include their corresponding software and self-adhesive labels type QR, NFC or similar, and includes the following stages: a) One or more drug manufacturing companies are registered in the system by assigning each company a company code, 5 10 fifteen twenty 25 30 b) The said companies register their medications in the system by means of the corresponding national code and barcode associated to said medications including at least the information necessary for their correct use, c) The system assigns to each of the medications discharged a medication code, d) The professionals of the health sector register in the system and the system generates a professional code, e) Self-adhesive labels are generated, each of the self-adhesive labels incorporates a specific label code in its QR code or NFC chip, f) The patient downloads the corresponding software on his smart mobile phone, g) The system generates a patient code, h) The patient attaches the self-adhesive label to the medication container, i) The patient activates the label by reading the label code incorporated in the QR code or in the NFC Chip of the self-adhesive label by reading it by the smart mobile phone, j) The patient enters the national code or bar code of the medication into the system through his smart mobile phone, k) The system generates an installation code for said label and said container and sends the medication information to the smart mobile phone, l) The patient checks that the downloaded medication information matches the medication, m) The patient enters into the system through his smart mobile phone the guidelines of the treatment prescribed by the doctor, including at least the frequency, the schedules of each take and the duration of the same, n) The mobile smart phone issues a warning at the time of dose taking, o) The patient reads the label code, through his smart mobile phone, of the self-adhesive label incorporated in the medicine container and the said telephone: to. Stops the warnings associated with that take, b. Verify that the medication is the medication to be taken by the patient, C. Receive that the dose of the medication has been administered, d. Informs the medication administration system and the said system processes and stores such information, and. Prepare the next notice 5 10 fifteen twenty 25 30 35 p) If the patient does not read the tag code through his mobile phone in a predetermined period of time from the notice, the said phone records the capture as not made q) If the package has been used up, the system deactivates the self-adhesive label incorporated into said package by marking the label code and the installation code, r) If the treatment is to be continued, a new self-adhesive label must be attached to a new container and the procedure is repeated from step h). Preferred embodiment Next, a preferred embodiment of the procedure for controlling adherence to medical treatments is described, which is the object of the present description. The procedure, which is carried out through the use of an computer system comprising a web server, which includes a loaded web server software, one or more mobile smart phones or similar devices, which include their corresponding software, and self-adhesive type labels QR, NFC or similar, includes the following stages: a) One or more drug manufacturing companies are registered in the system by assigning each company a company code, b) The said companies register their medications in the system by means of the corresponding national code and barcode associated to said medications including at least the information necessary for their correct use, c) The system assigns to each of the medications discharged a medication code, d) The professionals of the health sector are registered in the system and the system generates a professional code. If the medical professional is the prescribing physician of the medication, a professional medical code would be generated, if it were a pharmacist, a professional pharmaceutical code would be generated and if it were nurses, the code would be a professional nurse code. e) Self-adhesive labels are generated, each of the self-adhesive labels incorporates a specific label code in its QR code or NFC chip, f) The patient downloads the corresponding software on his smart mobile phone, not having to enter any personal data, so that all the information generated is anonymous, g) The system generates a patient code, 5 10 fifteen twenty 25 30 35 h) The patient attaches the self-adhesive label to the medication container, i) The patient activates the label by reading the label code incorporated in the QR code or in the NFC Chip of the self-adhesive label by reading it by the smart mobile phone, j) The patient enters the national code or bar code of the medication into the system through his smart mobile phone, k) The system generates an installation code for said label and said container and sends the medication information to the smart mobile phone, l) The patient checks that the downloaded medication information matches the medication, m) The patient enters into the system through his smart mobile phone the guidelines of the treatment prescribed by the doctor, including at least the frequency, the schedules of each take and the duration of the same, n) The mobile smart phone issues a warning at the time of dose taking, o) The patient reads the label code, through his smart mobile phone, of the self-adhesive label incorporated in the medicine container and the said telephone: to. Stops the warnings associated with that take, b. Verify that the medication is the medication to be taken by the patient, C. Receive that the dose of the medication has been administered, d. Informs the medication administration system and the said system processes and stores such information, and. Prepare the next notice p) If the patient does not read the tag code through his mobile phone in a predetermined period of time from the notice, the said phone records the capture as not made q) If the package has been used up, the system deactivates the self-adhesive label incorporated into said package by marking the label code and the installation code, r) If the treatment is to be continued, a new self-adhesive label must be attached to a new container and the procedure is repeated from step h). The system can include in the self-adhesive labels: • Only the tag code in which case the tags are called pre-associated. In this preferred embodiment, the identification of the drug by the system is performed upon receipt of said system and the national code or bar code of the container introduced by the patient. 5 10 fifteen twenty 25 30 • The label code and the company code, in which case the labels are called pre-associated to the company and can only be used with the medicines discharged by that company. In this case, the identification of the drug by the system is performed upon receipt of said system, the company code and the national code or the bar code of the container introduced by the patient. • The label code and the medicine code, in which case the labels are called pre-associated to the product and can only be used with that particular medicine. The identification of the medication by the system is made upon receipt of the said medication code. The procedure allows health professionals to access the information stored on a patient's web server if the patient enters the professional code through their mobile mobile phone and verify the degree of adherence to the treatment to take in their In case of necessary corrective measures. It also allows a supervisor or guardian who has downloaded the corresponding software on their smart mobile phone and therefore the system will have generated a supervisory code to access the stored information of a patient if he, analogously to what he does with his doctor, Enter the supervisor code in the system. Likewise, companies can access the stored information on the adherence of their discharged medications by entering their company code. For any healthcare professional or who is involved in the pharmaceutical industry, in the institutions concerned or in the state departments of health, the advantages of the implementation of this procedure are evident, but it is considered appropriate to highlight the main advantage is that the actors that take part in the treatments can access information about the adherence to a specific medicine or to a plurality of medicines, being able to take the pertinent corrective measures, which can range from varying the treatment to changing the presentations and formats of the medicines with what the effectiveness of The treatment is improved and there are considerable savings in spending on medicines.
权利要求:
Claims (8) [1] 5 10 fifteen twenty 25 30 1. Procedure for controlling adherence to medical treatments, through computer systems of those that comprise a web server that includes a loaded web server software, one or more smart mobile phones that include their corresponding software and self-adhesive labels type QR, NFC or similar, characterized in that it comprises the following stages: to. One or more drug manufacturing companies are registered in the system by assigning each company a company code, b. These companies register their medications in the system by means of the corresponding national code and barcode associated with said medications, including at least the information necessary for their correct use, C. The system assigns to each of the medications discharged a medication code, d. The professionals of the health sector are registered in the system and the system generates a professional code, and. Self-adhesive labels are generated, each of the self-adhesive labels incorporates a specific label code in its QR code or NFC chip, F. The patient downloads the corresponding software on their smart mobile phone, g. The system generates a patient code, h. The patient attaches the self-adhesive label to the medication container, i. The patient activates the tag by reading the tag code incorporated in the QR code or in the NFC Chip of the self-adhesive tag by reading it by the smart mobile phone, j. The patient identifies the medication through his smart mobile phone, k. The system generates an installation code for said label and said container and sends the medication information to the smart mobile phone, l. The patient checks that the downloaded medication information matches the medication, 5 10 fifteen twenty 25 30 m. The patient enters into the system through his smart mobile phone the guidelines of the treatment prescribed by the doctor, including at least the frequency, the schedules of each take and the duration of the same, n. The mobile smart phone issues a warning at the time of dose taking, or. The patient reads the label code, by means of his smart mobile phone, of the self-adhesive label incorporated in the medicine container and the said telephone: i. Stops the warnings associated with that take, ii. Verify that the medication is the medication to be taken by the patient, iii. Receive that the dose of the medication has been administered, iv. Informs the medication administration system and the said system processes and stores such information, v. Prepare the next notice p. If the patient does not read the tag code through his mobile phone within a predetermined period of time from the notice, the said phone records the capture as not made. q. If the package has been used up, the system deactivates the self-adhesive label incorporated into said package by marking the label code and the installation code, r. If the treatment is to be continued, a new self-adhesive label must be attached to a new container and the procedure is repeated from step h). [2] 2. Adherence control procedure to medical treatments, according to claim 1, characterized in that the identification of the medicament by the system is carried out upon receiving said system and the national code or the bar code of the container introduced by the patient. [3] 3. Adherence control procedure to medical treatments, according to claim 1, characterized in that when generating the self-adhesive label the system includes the company code and because the identification of the drug by the system is made upon receiving said system the company code and the national code or the bar code of the container introduced by the patient . 5 10 fifteen twenty 25 [4] 4. Procedure for controlling adherence to medical treatments, according to claim 1, characterized in that when generating the self-adhesive label the system includes the medication code and because the identification of the medication by the system is performed upon receipt of said medication code. [5] 5. Adhesion control procedure to medical treatments, according to claim 1, characterized in that the patient authorizes a healthcare professional to access the information stored on the web server about their adherence to the treatment by entering the said smart mobile phone of the professional code assigned to said healthcare professional. [6] 6. Procedure for controlling adherence to medical treatments, according to any of the preceding claims, characterized in that a corresponding supervisor of the patient downloads the corresponding software to his smart mobile phone and the system assigns a supervisory code. [7] 7. Adhesion control procedure to medical treatments, according to claim 6, characterized in that the patient authorizes his supervisor access to the information stored on the web server about his adherence to the treatment by introducing said intelligent mobile phone of the patient of the supervisory code. [8] 8. Procedure for controlling adherence to medical treatments, according to any of the preceding claims, characterized in that the companies access the information of adherence to the treatment of their medications stored on the web server by entering their company code.
类似技术:
公开号 | 公开日 | 专利标题 US11188873B2|2021-11-30|Remotely-executed medical therapy device US20200342782A1|2020-10-29|Apparatus and Method for Recognition of Patient Activities ES2769303T3|2020-06-25|Event Pointing Analysis and Medication Management System KR20060038936A|2006-05-04|System and method for drug management utilizing transferable labels ES2262842T3|2006-12-01|SYSTEM AND PROCEDURE FOR THE REALIZATION OF RECIPES. Chapuis et al.2015|Automated drug dispensing systems in the intensive care unit: a financial analysis US20100036678A1|2010-02-11|Systems and methods for providing a pharmaceutical to a patient US20090187424A1|2009-07-23|System and method for monitoring and recording locations of medical products and applications thereto Tadic et al.2015|Oral administration of antineoplastic agents: the challenges for healthcare professionals ES2608898B1|2018-02-07|Control procedure for adherence to medical treatments US20140074505A1|2014-03-13|System and method for managing the distribution ofmedication to patients JP2006181303A|2006-07-13|Medical malpractice preventing system BR102018010422A2|2019-12-10|app to integrate patients, pharmacies and healthcare services using the locator EP3200107A1|2017-08-02|Method associating computer programs and the packaging of drugs in order to improve the compliance with medical treatments by patients receiving out-patient care Karami2017|Pharmacy informatics: A reform at drug consumption management in healthcare TW202022785A|2020-06-16|Pillbox management method KR20210066553A|2021-06-07|Emergency patient medical information providing system and method TW202146066A|2021-12-16|Drug administration monitoring system Haberkorn2018|Easy to reach and ready to help: not just dispensing medication Leifeste2014|Oral antineoplastics in nononcology units: moving toward safer ordering, administration, and handling. Petrova et al.2021|Application Of Digital Technologies In The Pharmaceutical Sector US20180082039A1|2018-03-22|Prescription dispensing system and method of operation Rhodes et al.2019|Structure and organization of pharmacy Dullea2021|Medical Device Regulation 2017/745: Health Services Executive Webinar Venter2015|An international pharmacy perspective-pharmintercom 2015: pharmaceutical practitioner
同族专利:
公开号 | 公开日 ES2608898B1|2018-02-07|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题 US20030052788A1|2001-09-19|2003-03-20|Kevin Kwong-Tai Chung|Medical assistance and tracking system and method employing smart tags| US20120183941A1|2005-10-07|2012-07-19|Barcoding, Inc.|Apparatus, Method, Device And Computer Program Product For Audibly Communicating Medicine Identity, Dosage And Intake Instruction| US20140006040A1|2012-06-29|2014-01-02|Evondos Oy|Home healthcare system including medication administration system and method of dispensing medicines| US20150317455A1|2013-03-14|2015-11-05|The Research Foundation For The State University Of New York|Home medication manager| WO2014197774A2|2013-06-06|2014-12-11|Janssen Pharmaceutica Nv|Electronic medication adherence, identification, and dispensation|
法律状态:
2018-02-07| FG2A| Definitive protection|Ref document number: 2608898 Country of ref document: ES Kind code of ref document: B1 Effective date: 20180207 |
优先权:
[返回顶部]
申请号 | 申请日 | 专利标题 ES201631626A|ES2608898B1|2016-12-20|2016-12-20|Control procedure for adherence to medical treatments|ES201631626A| ES2608898B1|2016-12-20|2016-12-20|Control procedure for adherence to medical treatments| 相关专利
Sulfonates, polymers, resist compositions and patterning process
Washing machine
Washing machine
Device for fixture finishing and tension adjusting of membrane
Structure for Equipping Band in a Plane Cathode Ray Tube
Process for preparation of 7 alpha-carboxyl 9, 11-epoxy steroids and intermediates useful therein an
国家/地区
|